Just weeks after passing legislation to prohibit drugmaker 340B contract pharmacy restrictions in the state, Kansas lawmakers voted late Tuesday [...] …
Articles by : Shannon Young, Associate Editor
The Missouri Senate yesterday overwhelmingly passed a 340B contract pharmacy access bill, two weeks after the state house passed a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Kansas Gov. Laura Kelly (D) signed a sweeping state budget bill late Wednesday that contains a provision to prohibit drugmaker [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A small business lobbying organization, created as a more conservative alternative to the U.S. Chamber of Commerce, this week launched [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B drug discount program—and congressional activity associated with it—remained a hot topic for lobbyists in the first three months [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Thousands of covered entities that purchased more than one hundred Novartis products between late 2019 and early 2023 will be [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key New York senator has introduced legislation that would bar pharmaceutical manufacturers and pharmacy benefit managers (PBMs) from discriminating [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Merck has added an injectable medication used to treat pulmonary arterial hypertension—a type of high blood pressure which affects the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Tennessee sexually transmitted disease (STD) clinics will need to have contracts in place with the state to receive 340B in-kind [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Medicare paid hospitals substantially more—almost $4 billion in aggregate—than the 340B ceiling price costs for dozens of single-source drugs, biologics [...] …